National Vision is one of the largest optical retailers in the United States, operating brands such as America's Best Contacts & Eyeglasses and Eyeglass World. The fourth-quarter and full-year fiscal 2025 results matter because they show whether the company's multi-year transformation strategy is translating into durable profitability. Over the past year, management has deliberately shifted its customer mix toward higher-value segments, including managed care, progressive lens wearers, and outside prescription customers, while reducing reliance on lower-margin self-pay shoppers. Investors are watching whether this mix shift can sustain margin growth even as overall customer traffic softens. The latest report provided an important read on that trade-off. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
National Vision reported fourth-quarter 2025 net revenue of $503.4 million, an increase of 15.1% from $437.3 million in the prior-year period. Results included a 53rd week that added roughly $35.6 million to net revenue and approximately $0.03 to diluted EPS. Adjusted comparable-store sales growth was 4.8% for the quarter, driven by a higher average ticket, which rose 5.8%, partially offset by a 2.5% decline in customer traffic.
Adjusted diluted EPS from continuing operations came in at $0.15, versus a loss of $0.04 a year ago. Adjusted operating income surged to $17.6 million from $3.2 million, lifting adjusted operating margin to 3.5% from 0.7%. For full fiscal 2025, net revenue increased 9% to $1.99 billion, and adjusted operating income grew about 56% to $102.5 million, with adjusted EPS rising to $0.80 from $0.52.
National Vision shares rose about 9% following the earnings announcement, reflecting investor approval of the company's stronger-than-expected profitability. The fourth-quarter adjusted EPS and revenue both exceeded consensus estimates, and the margin expansion signaled that the strategic shift toward higher-value customers is gaining traction. Sentiment was further supported by management's raised full-year outlook and progress on cost discipline. At the same time, the continued decline in self-pay customer traffic remained a point of caution, as some investors questioned how long the mix-driven margin gains can offset softer volume.
Looking ahead, National Vision guided to fiscal 2026 net revenue of approximately $2.03 billion to $2.09 billion, with adjusted comparable-store sales growth of 3% to 6%. The company expects adjusted operating income between $107 million and $133 million and adjusted diluted EPS between $0.85 and $1.09.
Several factors will shape the next few quarters. First, investors should watch whether the expansion of premium frames and branded assortments continues to lift average ticket and margins. Management noted that frames priced above $99 have grown to roughly 40% of sales, up from about 20% at the start of fiscal 2025.
Second, the rollout of smart eyewear, including Ray-Ban Meta products, offers a potential new growth vector, though its financial contribution remains modest for now. Third, cost optimization remains a priority, with management identifying roughly $20 million of cost-out opportunities and expecting about $10 million in annualized savings in 2026.
Finally, the company plans to open about 30 to 35 new stores while closing 10 to 15 underperformers, resulting in net unit growth of roughly 20 to 25 locations. Balancing this expansion against softer self-pay traffic will be central to sustaining the turnaround.
I often turn to Tickeron’s AI Screener when analyzing earnings reports like this one. It helps me quickly filter stocks by fundamentals, technical patterns, and AI signals, giving me a clearer view of how EYE stacks up against peers before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
EYE moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend. In 40 of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on EYE as a result. In 63 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for EYE just turned positive on November 04, 2026. Looking at past instances where EYE's MACD turned positive, the stock continued to rise in 35 of 45 cases over the following month. The odds of a continued upward trend are 78%.
The 10-day moving average for EYE crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 84%.
Following a +6.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where EYE advanced for three days, in 204 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
EYE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 162 of 263 cases where EYE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
The 10-day RSI Indicator for EYE moved out of overbought territory on October 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 25 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 86%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EYE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. EYE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.578) is normal, around the industry mean (2.289). P/E Ratio (28.413) is within average values for comparable stocks, (17.578). EYE's Projected Growth (PEG Ratio) (0.050) is slightly lower than the industry average of (1.159). Dividend Yield (0.000) settles around the average of (0.102) among similar stocks. P/S Ratio (0.657) is also within normal values, averaging (1.057).
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EYE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of retail locations offering eye exams, eyeglasses and contact lenses
Industry SpecialtyStores